Ajay Gupta,Raumond Pratt,Vivian H. Lin,Carrue Guss
申请号:
US15033846
公开号:
US20160250254A1
申请日:
2014.11.04
申请国别(地区):
US
年份:
2016
代理人:
摘要:
The invention provides for methods of treating a dialysis patient that is hyporesponsive to erythropoietin stimulating agents (ESA) comprising administering soluble ferric triphosphate (SFP) composition and administering a dose of ESA that is significantly reduced compared to the dose of ESA required by a dialysis patient that is hyporesponsive to ESA that has not received SFP.